Screener
Regenxbio RGNX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
FAQ
- What is Regenxbio's total liabilities?
- Regenxbio (RGNX) reported total liabilities of $314.85M in Q2 2026.
- How has Regenxbio's total liabilities changed year-over-year?
- Regenxbio's total liabilities decreased by 14.3% year-over-year, from $367.35M to $314.85M.
- What is the long-term trend for Regenxbio's total liabilities?
- Over 5 years (2020 to 2025), Regenxbio's total liabilities has grown at a 1.2% compound annual growth rate (CAGR), from $330.41M to $350.3M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Regenxbio's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude